MetaCap

Cumberland Pharmaceuticals (CPIX) vs Upstream Bio (UPB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cumberland Pharmaceuticals (CPIX) has outperformed Upstream Bio (UPB) over the past year, gaining 193.5% versus a loss of 93.8%. Cumberland Pharmaceuticals is the larger company by market cap ($87.6 million vs $87.2 million), about 1.0 times the size, while Upstream Bio is growing revenue faster (+20.4% vs +17.6%). Cumberland Pharmaceuticals converts more of its revenue into profit, with a net margin of -6.4% versus -5026.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CPIX+193.47%UPB-93.78%
+373%+128%-116%
Nov 21, 20251 yearNov 20, 2026
CPIX+345.80%UPB-92.77%
+580%+228%-125%
Oct 7, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CPIX versus UPB key metrics
MetricCPIXUPB
Share price$5.84$1.59
Market cap$87.57M$87.15M
1-day change-7.30%-20.50%
YTD return+46.73%-94.14%
1-year return+193.47%-93.78%
5-year return+161.88%—
Forward P/E41.71—
EPS (TTM)$-0.57$-3.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$44.52M$2.85M
Revenue growth (YoY)+17.57%+20.42%
Net income (latest FY)$-2.84M$-143.44M
Gross margin85.02%—
Operating margin-6.27%-5618.82%
Net margin-6.37%-5026.03%
52-week high$9.28$33.68
52-week low$2.00$1.56
Distance from 52-week high-37.07%-95.28%
Analyst consensus—buy
Avg. price target upside—+1245.91%
Average volume114.52K1.01M
Shares outstanding15.00M54.81M
Employees8875
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CPIX has outperformed UPB by 287.2 percentage points over the past year.
  • Cumberland Pharmaceuticals is more profitable, keeping -6.4 cents of every revenue dollar as net income versus -5026.0 cents for Upstream Bio.

About Cumberland Pharmaceuticals

CPIX stock →

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.

Health Care · Biotechnology: Pharmaceutical Preparations · 88 employees

About Upstream Bio

UPB stock →

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease.

Health Care · Biotechnology: Pharmaceutical Preparations · 75 employees

CPIX vs UPB FAQ

Which is bigger, Cumberland Pharmaceuticals or Upstream Bio?

Cumberland Pharmaceuticals (CPIX) is larger, with a market capitalization of $87.57M compared with $87.15M for Upstream Bio (UPB).

Which stock has performed better over the past year, CPIX or UPB?

CPIX returned +193.47% over the past 12 months, compared with -93.78% for UPB (price return, excluding dividends). Past performance does not predict future results.

Are Cumberland Pharmaceuticals and Upstream Bio in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons